 | Up a level |
Grimminger, P. P., Shi, M., Barrett, C., Lebwohl, D., Danenberg, K. D., Brabender, J., Vigen, C. L. P., Danenberg, P. V., Winder, T. and Lenz, H-J (2012). TS and ERCC-1 mRNA expressions and clinical outcome in patients with metastatic colon cancer in CONFIRM-1 and-2 clinical trials. Pharmacogenomics J., 12 (5). S. 404 - 412. LONDON: NATURE PUBLISHING GROUP. ISSN 1473-1150
Maus, M. K. H., Grimminger, P. P., Mack, P. C., Astrow, S. H., Stephens, C., Zeger, G., Hsiang, J., Brabender, J., Friedrich, M., Alakus, H., Hoelscher, A. H., Lara, P., Danenberg, K. D., Lenz, H. J. and Gandara, D. R. (2014). KRAS mutations in non-small-cell lung cancer and colorectal cancer: Implications for EGFR-targeted therapies. Lung Cancer, 83 (2). S. 163 - 168. CLARE: ELSEVIER IRELAND LTD. ISSN 1872-8332
Odenthal, M., Bollschweiler, E., Grimminger, P. P., Schroeder, W., Brabender, J., Drebber, U., Hoelscher, A. H., Metzger, R. and Vallboehmer, D. (2013). MicroRNA profiling in locally advanced esophageal cancer indicates a high potential of miR-192 in prediction of multimodality therapy response. Int. J. Cancer, 133 (10). S. 2454 - 2464. HOBOKEN: WILEY-BLACKWELL. ISSN 0020-7136
Vallboehmer, D., Bollschweiler, E., Brabender, J., Wedemeyer, I., Grimminger, P. P., Metzger, R., Schroeder, W., Gutschow, C., Hoelscher, A. H. and Drebber, U. (2012). Evaluation of histological regression grading systems in the neoadjuvant therapy of rectal cancer. Int. J. Colorectal Dis., 27 (10). S. 1295 - 1302. NEW YORK: SPRINGER. ISSN 0179-1958